China Health Technology Group Holding Company Limited
CHBOD
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 6.61% | -7.84% | -22.02% | 21.28% | 135.82% |
| Total Other Revenue | -- | -- | -- | -2.20% | -- |
| Total Revenue | 6.61% | -7.84% | -22.02% | 21.28% | 135.82% |
| Cost of Revenue | 28.97% | 10.95% | -6.86% | 34.08% | 146.09% |
| Gross Profit | -91.11% | -87.32% | -84.22% | -29.06% | 99.44% |
| SG&A Expenses | -0.58% | 4.97% | 10.47% | 71.56% | 284.48% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 18.91% | 9.05% | -1.72% | 33.51% | 110.89% |
| Operating Income | -71.55% | -99.19% | -139.79% | -92.33% | -45.21% |
| Income Before Tax | -98.10% | 11.57% | 2,144.85% | 3,617.86% | 15,054.65% |
| Income Tax Expenses | -95.39% | -97.48% | -99.61% | -1.82% | -- |
| Earnings from Continuing Operations | -98.12% | 13.38% | 1,874.53% | 3,188.07% | 14,939.07% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -98.12% | 13.38% | 1,874.53% | 1,529.26% | 1,274.12% |
| EBIT | -71.55% | -99.19% | -139.79% | -92.33% | -45.21% |
| EBITDA | -70.13% | -97.34% | -137.16% | -247.34% | -159.91% |
| EPS Basic | -98.12% | 152.71% | 412.24% | 321.72% | 255.97% |
| Normalized Basic EPS | 90.59% | 91.53% | 92.36% | 23.86% | -368.34% |
| EPS Diluted | -98.12% | 152.71% | 412.24% | 321.72% | 255.97% |
| Normalized Diluted EPS | 90.59% | 91.53% | 92.36% | 23.86% | -368.34% |
| Average Basic Shares Outstanding | 104.45% | 197.56% | 509.04% | 371.78% | 346.02% |
| Average Diluted Shares Outstanding | 104.45% | 197.56% | 509.04% | 371.78% | 234.52% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |